Translational Session

Needle Phobia: Kidney Transplant Biopsy Alternatives

November 07, 2019 | 10:30 AM - 12:30 PM

Location: 151, Walter E. Washington Convention Center

Session Description

A number of noninvasive approaches to the diagnosis of rejection have been advanced to the clinical realm, but which one to use, if any, is uncertain. This session reviews the pros and cons of the most common approaches.

Learning Objective(s)

  • Discuss the limitations of the renal allograft biopsy in the diagnosis of rejection
  • Describe the use and limitations of cell-free DNA technologies
  • Explain the use and limitations of urinary chemokines
  • Describe the use and limitations of the blood-based molecular biomarker platform to diagnose rejection

Learning Pathway(s)

  • Transplantation/Immunology
  • Pathology


  • Darshana Dadhania, MD, MS
  • Roslyn B. Mannon, MD, FASN


  • Is Biopsy Still the Gold Standard?
    10:30 AM - 11:00 AM
    Mei Lin Bissonnette, MD, PhD 
  • Cell-Free DNA
    11:00 AM - 11:30 AM
    Roy D. Bloom, MD
  • Urinary Chemokines
    11:30 AM - 12:00 PM
    Peter S. Heeger, MD
  • Molecular Biomarkers in the Peripheral Blood
    12:00 PM - 12:30 PM
    John J. Friedewald, MD, FASN